Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S. Ireland, Alexi M. Micinski, David W. Kastner, et al.
Cancer Cell (2020) Vol. 38, Iss. 1, pp. 60-78.e12
Open Access | Times Cited: 388

Showing 1-25 of 388 citing articles:

Small-cell lung cancer
Charles M. Rudin, Élisabeth Brambilla, C. Faivre‐Finn, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 996
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M. Gay, C. Allison Stewart, Elizabeth M. Park, et al.
Cancer Cell (2021) Vol. 39, Iss. 3, pp. 346-360.e7
Open Access | Times Cited: 678
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K. Baine, Min‐Shu Hsieh, W. Victoria Lai, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 12, pp. 1823-1835
Open Access | Times Cited: 370
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Joseph M. Chan, Álvaro Quintanal-Villalonga, Vianne R. Gao, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1479-1496.e18
Open Access | Times Cited: 280
Mechanisms of small cell lung cancer metastasis
Julie H. Ko, Monte M. Winslow, Julien Sage
EMBO Molecular Medicine (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 168
Cells of origin of lung cancers: lessons from mouse studies
Giustina Ferone, Myung Chang Lee, Julien Sage, et al.
Genes & Development (2020) Vol. 34, Iss. 15-16, pp. 1017-1032
Open Access | Times Cited: 157
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Navin R. Mahadevan, Erik H. Knelson, Jacquelyn O. Wolff, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1952-1969
Open Access | Times Cited: 144
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
Joel D. Pearson, Katherine Huang, Marek Pacal, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1115-1134.e12
Open Access | Times Cited: 120
A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates
Peng He, Kyungtae Lim, Dawei Sun, et al.
Cell (2022) Vol. 185, Iss. 25, pp. 4841-4860.e25
Open Access | Times Cited: 120
Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
Nitin Roper, Moises J. Velez, Alberto Chiappori, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 116
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
Yijian Zhang, Chunman Zuo, Liguo Liu, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 5, pp. 1128-1141
Open Access | Times Cited: 115
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes
Christina M. Bebber, Emily Thomas, Jenny Stroh, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 107
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
Paloma Cejas, Yingtian Xie, Alba Font‐Tello, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers
Song Qu, Patricia Fetsch, Anish Thomas, et al.
Journal of Thoracic Oncology (2021) Vol. 17, Iss. 1, pp. 141-153
Open Access | Times Cited: 103
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
Tian Li, Tianyun Qiao
Seminars in Cancer Biology (2022) Vol. 86, pp. 117-125
Closed Access | Times Cited: 89
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
Hirokazu Taniguchi, Rebecca Caeser, Shweta S. Chavan, et al.
Cell Reports (2022) Vol. 39, Iss. 7, pp. 110814-110814
Open Access | Times Cited: 84
cfDNA methylome profiling for detection and subtyping of small cell lung cancers
Francesca Chemi, Simon P. Pearce, Alexandra Clipson, et al.
Nature Cancer (2022) Vol. 3, Iss. 10, pp. 1260-1270
Open Access | Times Cited: 84
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models
Delphine Lissa, Nobuyuki Takahashi, Parth Desai, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 74
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer
Yanhua Tian, Qingqing Li, Zhenlin Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 70
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
Lőrinc Sándor Pongor, Christopher W. Schultz, Lorenzo Rinaldi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 928-949
Open Access | Times Cited: 57
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 50
Evolutionary trajectories of small cell lung cancer under therapy
Julie George, Lukas Maas, Nima Abedpour, et al.
Nature (2024) Vol. 627, Iss. 8005, pp. 880-889
Open Access | Times Cited: 42
Lineage-specific intolerance to oncogenic drivers restricts histological transformation
Eric E. Gardner, Ethan M. Earlie, Kate Li, et al.
Science (2024) Vol. 383, Iss. 6683
Open Access | Times Cited: 34
Molecular profile of bladder cancer progression to clinically aggressive subtypes
Charles C. Guo, Sangkyou Lee, June G. Lee, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 7, pp. 391-405
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top